The data[1] shows: While the rest of the prescription opioid market was growing, OxyContin’s market share was generally shrinking. OxyContin has never been more than 4% of opioid prescriptions (market share peaked in 2001; overall prescriptions peaked in 2003). OxyContin was only 1.4% of opioid prescriptions as of September 2018. All Opioid Prescriptions: 1992–2018 OxyContin’s … Continue reading OxyContin’s Market Share Has Always Been Small